Listing of New BMRB NMR-STAR files
Entries released in the last month, starting from most recent release to least recent one.
The latest entries may not be immediately available here
or through the BMRB database search. They can be found in "entry lists" under "FTP access".
| Entry ID | Release Date | Title |
|---|---|---|
| 34999 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 35000 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 34996 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 53674 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53673 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53672 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53671 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53637 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53626 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53675 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53639 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53638 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53636 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53670 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53669 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53668 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53667 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53666 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53665 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53664 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53662 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53661 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53660 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53659 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53658 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53657 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53656 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53655 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53654 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53653 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53652 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53651 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53650 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 52336 | 2026-04-14 | A dynamic structural unit of phase-separated heterochromatin protein 1a as revealed by integrative structural analyses |
| 53649 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53648 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53647 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53646 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53645 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53644 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53643 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53642 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53641 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53640 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53701 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53702 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53703 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53213 | 2026-04-09 | Beyond formic acid: Peptides in carpenter ant venoms aid in disease protection |
| 53225 | 2026-04-09 | Beyond formic acid: Peptides in carpenter ant venoms aid in disease protection |
| 53513 | 2026-04-01 | Manuscripts that utilise GB1-TACC3 |
| 35028 | 2026-04-01 | Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity |
| 35032 | 2026-04-01 | Xeno amino acid alphabets form peptides with familiar secondary structure |
| 31206 | 2026-03-31 | BLM G-quadruplex stabilizers synergize with PARP inhibitor to kill BRCA wild-type colon cancer cells |
| 31201 | 2026-03-31 | NMR structures of small molecules bound to a model of an RNA CAG repeat expansion. |
| 36724 | 2026-03-31 | Transgenic Tobacco Plants Expressing Synthetic Peptides: A Functional and Structural Analysis for Pathogen Resistance. |
| 36715 | 2026-03-31 | Lipidic-Abeta40 fibril structure analyzed by Solid-state NMR |
| 26376 | 2026-03-31 | 1H, 13C, and 15N backbone resonance assignments of the A2 domain of human von Willebrand factor |
| 36774 | 2026-03-31 | Solution structure of Z-form DNA bound to a curaxin ligand CBL0137. |
| 36768 | 2026-03-31 | Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer's disease risk factors. |
| 53602 | 2026-03-31 | HC-Fab Adalimumab |
| 31203 | 2026-03-31 | NMR structures of small molecules bound to a model of an RNA CAG repeat expansion. |
| 53491 | 2026-03-31 | Complete and Rapid NMR Characterization of Therapeutic Monoclonal Antibodies via Differential Labelling of Fab fragments in Escherichia coli |
| 31281 | 2026-03-31 | The R203W Substitution Drives PACS-1 Syndrome by Disrupting Intramolecular Regulation |
| 53440 | 2026-03-31 | Differential labelling of Fab fragments from therapeutic monoclonal antibodies in Escherichia coli allows complete NMR assignment of backbone and side-chain methyl resonances |
| 53199 | 2026-03-31 | NMR assignment of the Fc (fragment crystallizable) region of human immunoglobulin G1 glycoprotein of adalimumab, in non-fucosylated and non-galactosylated (G0) glycoforms |
| 53197 | 2026-03-31 | New approach to mAb production in Escherichia coli |
| 36490 | 2026-03-30 | Structural investigation of human U6 snRNA recognition by spliceosomal recycling factor SART3 RNA recognition motifs |
| 53407 | 2026-03-30 | Combining experiments and simulations to study the impact of multiple phosphorylations at the AT8 epitope of the Tau protein |
| 36491 | 2026-03-30 | Structural investigation of human U6 snRNA recognition by spliceosomal recycling factor SART3 RNA recognition motifs |
| 53623 | 2026-03-27 | Kinetic NMR screening to rapidly quantify ligand dissociation in fragment mixtures using 19F relaxation dispersion |
| 53619 | 2026-03-27 | Kinetic NMR screening to rapidly quantify ligand dissociation in fragment mixtures using 19F relaxation dispersion |
| 36699 | 2026-03-26 | A minimal RNA-cleaving DNAzyme and its catalytic mechanism. |
| 26339 | 2026-03-26 | (1)H, (13)C and (15)N backbone resonance assignments of hepatocyte nuclear factor-1-beta (HNF1b) POU(S) and POU(HD). |
| 52038 | 2026-03-26 | A single phosphorylation site modulates NFAT transactivation |
| 52037 | 2026-03-26 | A single phosphorylation site modulates NFAT transactivation |
| 36733 | 2026-03-26 | pH Sensitivity of the SERF1a Conformational Ensemble. |
| 36732 | 2026-03-26 | pH Sensitivity of the SERF1a Conformational Ensemble. |
| 36730 | 2026-03-26 | A Unique Class of Cyclases with a Kinase Fold Catalyzes Enethiol-Mediated Macrocyclization of Aminovinyl-Cysteine Motifs in Lanthipeptides. |
| 36703 | 2026-03-26 | Dynamic structures of a membrane transporter in native cellular membranes. |
| 36702 | 2026-03-26 | Dynamic structures of a membrane transporter in native cellular membranes. |
| 36305 | 2026-03-26 | Robust folding of a de novo designed ideal protein even with most of the core mutated to valine. |
| 36190 | 2026-03-26 | Design of therapeutically improved analogue of the antimicrobial peptide, indolicidin, using a glycosylation strategy. |
| 36189 | 2026-03-26 | Design of therapeutically improved analogue of the antimicrobial peptide, indolicidin, using a glycosylation strategy. |
| 26340 | 2026-03-26 | (1)H, (13)C and (15)N backbone resonance assignments of hepatocyte nuclear factor-1-beta (HNF1b) POU(S) and POU(HD). |
| 53521 | 2026-03-24 | 1H, 13C, and 15N resonance assignments of the N-terminal intrinsically disordered region and WGR domain of human PARP2 |
| 53522 | 2026-03-24 | 1H, 13C, and 15N resonance assignments of the N-terminal intrinsically disordered region and WGR domain of human PARP2 |
| 53455 | 2026-03-24 | Bacillus subtilis ParB C-terminal lysine residues are essential for dimerization and in vivo function, indicating their roles in DNA sliding |
| 53520 | 2026-03-24 | 1H, 13C, and 15N resonance assignments of the N-terminal intrinsically disordered region and WGR domain of human PARP2 |
| 35002 | 2026-03-23 | Structure-based rational design of an efficient SCoV-2 Nsp3 macro domain hydrolase inhibitor |
| 53625 | 2026-03-23 | Complete and Rapid NMR Characterization of Therapeutic Monoclonal Antibodies via Differential Labelling of Fab fragments in Escherichia coli |
| 34984 | 2026-03-23 | Mechanistic insights into the Auto-ubiquitiniation of ARKADIA 2C RING domain |
| 34983 | 2026-03-23 | Nociceptive properties of U5-theraphotoxin-Hs1b, a novel peptide from the Cyriopagopus schmidti spider, active on NaV1.7 channel |
| 53615 | 2026-03-23 | Molecular basis of protein-glycan cross-linking by CpCBM92A revealed by NMR spectroscopy |